Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Screening for epidermal growth factor receptor mutations in lung cancer.
Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larriba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N, Palmero R, Sánchez JM, Bastus R, Mayo C, Bertran-Alamillo J, Molina MA, Sanchez JJ, Taron M; Spanish Lung Cancer Group. Rosell R, et al. Among authors: bastus r. N Engl J Med. 2009 Sep 3;361(10):958-67. doi: 10.1056/NEJMoa0904554. Epub 2009 Aug 19. N Engl J Med. 2009. PMID: 19692684 Free article.
[Incidence of urinary bladder cancer in an industrialized area of Spain].
Urrutia G, Serra C, Bonfill X, Bastús R; Grupo Trabajo para el Estudio del Cancer de Vejiga Urinaria en la Comarca del Valles Occidental. Urrutia G, et al. Among authors: bastus r. Gac Sanit. 2002 Jul-Aug;16(4):291-7. doi: 10.1016/s0213-9111(02)71927-4. Gac Sanit. 2002. PMID: 12106548 Free article. Spanish.
Bladder cancer in the textile industry.
Serra C, Bonfill X, Sunyer J, Urrutia G, Turuguet D, Bastús R, Roqué M, 't Mannetje A, Kogevinas M; Working Group on the Study of Bladder Cancer in the County of Vallès Occidental. Serra C, et al. Among authors: bastus r. Scand J Work Environ Health. 2000 Dec;26(6):476-81. doi: 10.5271/sjweh.571. Scand J Work Environ Health. 2000. PMID: 11201394 Free article.
Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Aparicio J, García Del Muro X, Maroto P, Terrasa J, Castellano D, Bastús R, Gumà J, Sagastibeltza N, Durán I, Ochenduszko S, Meana JA, García-Sánchez J, Arranz JA, Gironés R, Germà JR. Aparicio J, et al. Among authors: bastus r. Clin Transl Oncol. 2021 Jan;23(1):58-64. doi: 10.1007/s12094-020-02393-9. Epub 2020 May 27. Clin Transl Oncol. 2021. PMID: 32462393
Malignant Pleural Mesothelioma: The Last 8 Years of Experience in Our Area.
Benítez JC, Campayo M, Call S, Bastús R. Benítez JC, et al. Among authors: bastus r. Arch Bronconeumol (Engl Ed). 2018 Dec;54(12):637-638. doi: 10.1016/j.arbres.2018.03.012. Epub 2018 May 24. Arch Bronconeumol (Engl Ed). 2018. PMID: 29804950 English, Spanish. No abstract available.
A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
Aparicio J, Sánchez-Muñoz A, Gumà J, Domenech M, Meana JA, García-Sánchez J, Bastús R, Gironés R, González-Billalabeitia E, Sagastibelza N, Ochenduszko S, Sánchez A, Terrasa J, Germà-Lluch JR, García Del Muro X; on behalf of the Spanish Germ Cell Cancer Group. Aparicio J, et al. Among authors: bastus r. Oncology. 2018;95(1):8-12. doi: 10.1159/000487438. Epub 2018 Mar 26. Oncology. 2018. PMID: 29587278
Prognostic and Predictive Factors for Renal Cell Carcinoma.
Suárez C, Campayo M, Bastús R, Castillo S, Etxanitz O, Guix M, Sala N, Gallardo E. Suárez C, et al. Among authors: bastus r. Target Oncol. 2018 Jun;13(3):309-331. doi: 10.1007/s11523-018-0557-2. Target Oncol. 2018. PMID: 29569164 Review.
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA; SQUIRE Investigators. Thatcher N, et al. Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1. Lancet Oncol. 2015. PMID: 26045340 Free article. Clinical Trial.
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
Paz-Ares L, Mezger J, Ciuleanu TE, Fischer JR, von Pawel J, Provencio M, Kazarnowicz A, Losonczy G, de Castro G Jr, Szczesna A, Crino L, Reck M, Ramlau R, Ulsperger E, Schumann C, Miziara JE, Lessa ÁE, Dediu M, Bálint B, Depenbrock H, Soldatenkova V, Kurek R, Hirsch FR, Thatcher N, Socinski MA; INSPIRE investigators. Paz-Ares L, et al. Lancet Oncol. 2015 Mar;16(3):328-37. doi: 10.1016/S1470-2045(15)70046-X. Epub 2015 Feb 18. Lancet Oncol. 2015. PMID: 25701171 Free article. Clinical Trial.
26 results